339 related articles for article (PubMed ID: 33649834)
1. SIRT1 and gynecological malignancies (Review).
Chen J; Chen H; Pan L
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649834
[TBL] [Abstract][Full Text] [Related]
2. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions.
Zhang T; Kraus WL
Biochim Biophys Acta; 2010 Aug; 1804(8):1666-75. PubMed ID: 19879981
[TBL] [Abstract][Full Text] [Related]
3. The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers.
Chelariu-Raicu A; Zibetti Dal Molin G; Coleman RL
Int J Gynecol Cancer; 2020 Oct; 30(10):1608-1618. PubMed ID: 32928926
[TBL] [Abstract][Full Text] [Related]
4. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
[TBL] [Abstract][Full Text] [Related]
5. 17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation.
Bendale DS; Karpe PA; Chhabra R; Shete SP; Shah H; Tikoo K
Br J Pharmacol; 2013 Oct; 170(4):779-95. PubMed ID: 23826814
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3.
Huang S; Li Y; Sheng G; Meng Q; Hu Q; Gao X; Shang Z; Lv Q
Cell Biol Int; 2021 May; 45(5):1050-1059. PubMed ID: 33438275
[TBL] [Abstract][Full Text] [Related]
7. Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX.
Yamagata K; Kitabayashi I
Biochem Biophys Res Commun; 2009 Dec; 390(4):1355-60. PubMed ID: 19895790
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted Modulation of SIRT1 in Cancer and Inflammation.
Yang H; Bi Y; Xue L; Wang J; Lu Y; Zhang Z; Chen X; Chu Y; Yang R; Wang R; Liu G
Crit Rev Oncog; 2015; 20(1-2):49-64. PubMed ID: 25746104
[TBL] [Abstract][Full Text] [Related]
9. A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer.
Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Li CY; Yang Q
Sci Rep; 2014 Oct; 4():6666. PubMed ID: 25323003
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.
Wu Y; Meng X; Huang C; Li J
Tumour Biol; 2015 Jun; 36(6):4063-74. PubMed ID: 25926383
[TBL] [Abstract][Full Text] [Related]
12. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
13. The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer.
Alves-Fernandes DK; Jasiulionis MG
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261609
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3.
Tong X; Wang X; Wang C; Li L
Br J Biomed Sci; 2018 Jan; 75(1):7-12. PubMed ID: 28929922
[TBL] [Abstract][Full Text] [Related]
15. Negative transcriptional regulation of inflammatory genes by group B3 vitamin nicotinamide.
Zhang XM; Jing YP; Jia MY; Zhang L
Mol Biol Rep; 2012 Dec; 39(12):10367-71. PubMed ID: 23053940
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin1-p53: A potential axis for cancer therapy.
Yin JY; Lu XT; Hou ML; Cao T; Tian Z
Biochem Pharmacol; 2023 Jun; 212():115543. PubMed ID: 37037265
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.
Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T
RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis.
Lin L; Zheng X; Qiu C; Dongol S; Lv Q; Jiang J; Kong B; Wang C
Oncol Rep; 2014 Dec; 32(6):2831-5. PubMed ID: 25270091
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
Hu N; Long H; Zhao M; Yin H; Lu Q
Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023
[TBL] [Abstract][Full Text] [Related]
20. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.
Bartosch C; Monteiro-Reis S; Almeida-Rios D; Vieira R; Castro A; Moutinho M; Rodrigues M; Graça I; Lopes JM; Jerónimo C
Oncotarget; 2016 Jan; 7(2):1144-54. PubMed ID: 26701732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
